Draegerwerk Stock Price, News & Analysis

DRAEGERWERK AG ORD (DGWPF) represents an interest in Dräger, an international medical and safety technology company. According to company disclosures, Dräger focuses on products and solutions that protect, support, and save lives in healthcare and safety-critical environments. The group traces its origins to its founding in 1889 in Lübeck, Germany, and reports that it is represented in more than 190 countries with many thousands of employees worldwide.

Across its activities, Dräger emphasizes two core fields: medical technology and safety technology. In medical technology, the company highlights solutions used in operating rooms, intensive care units, neonatal intensive care units (NICUs), and other clinical settings. In safety technology, Dräger develops equipment for first responders, government agencies, industrial users, and other professionals who operate in hazardous conditions. The company repeatedly states that its products are designed to protect people, patients, and missions in demanding environments.

Medical technology focus

Dräger describes itself as an international medical technology company with offerings that include anesthesia workstations, ventilators, neonatal care solutions, surgical lighting, and related systems. The Atlan A350/A350XL anesthesia machines are presented as anesthesia workstations designed to enhance patient safety and operational efficiency in operating rooms. They incorporate an electronic piston ventilator that can ventilate patients ranging from neonates to adults and include safety features intended to help prevent unintentional high tidal volumes and inspiratory pressures.

The company also points to its ventilation portfolio, including the Evita V800/V600, Babylog VN800, Savina 300 series, and earlier V500 series of ventilators. These devices are described as mechanical ventilators for critical care and neonatal care, with designs that support various acuity levels. Dräger notes that these ventilators have obtained Authority to Operate (ATO) certifications under the U.S. Department of Defense Risk Management Framework for specific system IDs, reflecting a focus on cybersecurity and integration into secure hospital and defense environments.

In neonatal care, Dräger reports an expanded portfolio that includes the Babylog VN800 ventilator and jaundice management solutions. The company highlights the Dräger Jaundice Meter JM-105 for non-invasive bilirubin measurement and the BiliLux phototherapy light for LED-based phototherapy. It also describes a collaboration with NeoPredics on BiliPredics, a predictive software solution intended to forecast bilirubin progression in newborns using a clinically validated algorithm and large underlying datasets. This application is presented as a web-based tool that can integrate with electronic medical records and align with established hyperbilirubinemia guidelines.

Neonatal education and extended reality

Beyond devices, Dräger describes work on immersive training tools. Together with VirtualiSurg, the company developed the Dräger Virtuo XR Babyleo extended reality simulator for NICU training. This solution is presented as an XR-based training environment that allows medical teams to practice clinical scenarios, communication, and empathy with parents in neonatal intensive care settings. According to the company, the simulator content is based on expert interviews, scientific literature, and parental stories, and it has been recognized with the Obsidian Award from the Academy of International Extended Reality.

Operating room lighting and infrastructure

Dräger reports that it supplies Polaris surgical lighting systems and equipment booms for operating rooms and other clinical environments. The Polaris OR lights are described as LED-based surgical lights with an optical system aimed at creating a homogeneous surgical field with smooth edges and a high color rendering index. Features mentioned include adjustable light field diameter and brightness, Light Guard functionality to limit total light energy irradiance to a specified safe value, and optional 4K MedView camera integration for high-resolution video recording.

The company notes that it has been awarded a five-year, single-award Non-Expendable Equipment Program contract by the U.S. Veterans Health Administration for surgical lighting and equipment booms. This contract makes Polaris surgical lighting and boom systems available through the VHA National Equipment Catalog, which the company describes as a streamlined path for VA medical centers to order these systems.

Safety technology and first responder equipment

In safety technology, Dräger highlights respiratory protection and alcohol detection products. The ProAir closed-circuit breathing apparatus (CCBA) is described as a long-duration breathing system designed for first responders and federal government operations in hazardous environments such as high-rise buildings, tunnels, subways, below-deck ship incidents, confined spaces, subterranean operations, and HAZMAT scenarios. The ProAir uses a proprietary carbon dioxide scrubber within a positive pressure breathing circuit to remove CO2 and enrich air with oxygen, reducing reliance on traditional air cylinders.

The ProAir is presented with features such as an extended-duration oxygen supply (up to about four hours), customizable cooling options using Ice Cooler packs or Phase Change Material sheets, flame resistance to specified temperatures, Buddy Lights for visibility, an electronic control unit for status information, integrated radio and voice amplification, and RFID-based tracking of soda lime life. Dräger positions this device as complementing traditional self-contained breathing apparatuses by extending operational time in complex environments.

In alcohol detection, Dräger describes the Alcotest 7000 as an advanced alcohol screening device intended for law enforcement, Department of Transportation (DOT) compliance, and workplace safety screening. The device offers dual-mode testing via a funnel-based prescreening option and a Slide 'n' Click mouthpiece for precise breath alcohol concentration measurement. Features mentioned include a full-color display, Bluetooth connectivity to mobile printers and apps, storage for up to 10,000 test results, and operating temperature ranges suitable for varied environments. A dedicated workplace version is described as supporting DOT protocols and incorporating safeguards such as automatic lockouts and quality assurance features.

Cybersecurity and government-focused certifications

Dräger emphasizes cybersecurity as part of its offering, particularly for government and defense healthcare customers. Draeger, Inc., part of the Dräger group, reports that it has achieved Cybersecurity Maturity Model Certification (CMMC) Level 2 with a perfect score of 110, aligned with NIST SP 800-171 standards. This certification is described as covering access management, incident response planning, training, and continuous system monitoring, and is positioned as important for handling Controlled Unclassified Information in the U.S. Department of Defense supply chain.

The company also notes that many of its medical devices are accredited under the U.S. Department of Defense Risk Management Framework (RMF). Specific ventilator families (Evita V800/V600, Babylog VN800, Savina 300 series, and earlier V500 series) are cited as having obtained Authority to Operate under designated eMASS system IDs. Dräger presents these certifications as evidence of its focus on secure and compliant solutions for government and defense healthcare environments.

Collaborations and recognition

Dräger references multiple collaborations and recognitions in its communications. It reports working with NeoPredics on predictive analytics for neonatal jaundice management and with VirtualiSurg on XR-based medical training. The company states that its Atlan A350/A350XL anesthesia machines have received an Innovative Technology Product designation from Vizient, Inc., and that it has been selected to exhibit Polaris surgical lights at the Vizient Innovative Technology Exchange. It also notes receiving the Obsidian Award for the Virtuo XR Babyleo project from the Academy of International Extended Reality.

Geographic reach and scale

Across several disclosures, Dräger states that it is represented in more than 190 countries and employs more than 14,000 to 16,000 people worldwide, with global sales figures in the multi-billion euro range in recent years. These statements underscore the company’s characterization of itself as a leading international medical and safety technology group with a broad geographic footprint.

DGWPF as an investment reference

DRAEGERWERK AG ORD (DGWPF) is associated with Dräger’s equity on international markets. While no U.S. SEC filings are listed for this symbol in the provided data, investors researching DGWPF typically examine Dräger’s global medical and safety technology activities, its certifications in healthcare and government markets, and its stated presence across hospital, neonatal, anesthesia, respiratory protection, and first responder applications.

Key themes for investors and researchers

• Medical devices and hospital infrastructure: anesthesia workstations, ventilators, neonatal jaundice management devices, surgical lighting, and OR boom systems.
• Neonatal and critical care focus: devices and software aimed at NICUs, jaundice screening and treatment, and neonatal ventilation.
• Safety and first responder equipment: closed-circuit breathing apparatuses and alcohol detection devices for law enforcement, workplace safety, and government operations.
• Cybersecurity and compliance: CMMC Level 2 certification and RMF/ATO certifications for selected devices in defense and government healthcare environments.
• Training and digital solutions: extended reality simulators for NICU training and predictive software for neonatal jaundice management.